IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.9700
-0.0600 (-5.83%)
At close: May 12, 2025, 4:00 PM
1.000
+0.030 (3.09%)
After-hours: May 12, 2025, 7:38 PM EDT
IceCure Medical Revenue
In the year 2024, IceCure Medical had annual revenue of $3.29M with 1.92% growth. IceCure Medical had revenue of $875.00K in the quarter ending December 31, 2024, a decrease of -30.28%.
Revenue (ttm)
$3.29M
Revenue Growth
+1.92%
P/S Ratio
15.00
Revenue / Employee
$49,864
Employees
66
Market Cap
54.87M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.29M | 62.00K | 1.92% |
| Dec 31, 2023 | 3.23M | 144.00K | 4.67% |
| Dec 31, 2022 | 3.09M | -1.05M | -25.45% |
| Dec 31, 2021 | 4.14M | 270.00K | 6.98% |
| Dec 31, 2020 | 3.87M | 2.21M | 132.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
ICCM News
- 6 days ago - IceCure Receives High Level of Interest from Breast Surgeons at ASBrS 2025 Annual Meeting Following Recent Positive FDA Development on ProSense® Cryoablation - PRNewsWire
- 12 days ago - IceCure Announces Positive FDA Development: Understanding on Path Forward for Marketing Authorization of ProSense® Cryoablation in Women 70+ with Early-Stage Breast Cancer - PRNewsWire
- 14 days ago - IceCure Exhibits ProSense® & Sponsors Breast Cryoablation Courses at the Society of Breast Imaging Symposium - PRNewsWire
- 20 days ago - IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation - PRNewsWire
- 6 weeks ago - IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America - PRNewsWire
- 7 weeks ago - IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate - PRNewsWire
- 7 weeks ago - IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 - PRNewsWire